Clinical Benefit of Fixed‐Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia
CP Lin, TJ Hsu, YC Tung, FC Hsiao, SH Chou… - Journal of the American … - Am Heart Assoc
Background Hypertension and hypercholesterolemia are important risk factors for
cardiovascular disease, and treatment with fixed‐dose combination (FDC) regimens is …
cardiovascular disease, and treatment with fixed‐dose combination (FDC) regimens is …
Clinical Benefit of Fixed-Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia.
CP Lin, TJ Hsu, YC Tung, FC Hsiao… - Journal of the …, 2024 - europepmc.org
Background Hypertension and hypercholesterolemia are important risk factors for
cardiovascular disease, and treatment with fixed-dose combination (FDC) regimens is …
cardiovascular disease, and treatment with fixed-dose combination (FDC) regimens is …
Clinical Benefit of Fixed-Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia
CP Lin, TJ Hsu, YC Tung, FC Hsiao, SH Chou, YS Lin… - 2024 - Am Heart Assoc
BACKGROUND: Hypertension and hypercholesterolemia are important risk factors for
cardiovascular disease, and treatment with fixed-dose combination (FDC) regimens is …
cardiovascular disease, and treatment with fixed-dose combination (FDC) regimens is …
Clinical Benefit of Fixed-Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia
CP Lin, TJ Hsu, YC Tung, FC Hsiao… - Journal of the … - pubmed.ncbi.nlm.nih.gov
Background Hypertension and hypercholesterolemia are important risk factors for
cardiovascular disease, and treatment with fixed-dose combination (FDC) regimens is …
cardiovascular disease, and treatment with fixed-dose combination (FDC) regimens is …